182 related articles for article (PubMed ID: 26558036)
1. Economics of stone disease/treatment.
Strohmaier WL
Arab J Urol; 2012 Sep; 10(3):273-8. PubMed ID: 26558036
[TBL] [Abstract][Full Text] [Related]
2. [Economic aspects of evidence-based metaphylaxis].
Strohmaier WL
Urologe A; 2006 Nov; 45(11):1406-9. PubMed ID: 17063349
[TBL] [Abstract][Full Text] [Related]
3. Course of calcium stone disease without treatment. What can we expect?
Strohmaier WL
Eur Urol; 2000 Mar; 37(3):339-44. PubMed ID: 10720863
[TBL] [Abstract][Full Text] [Related]
4. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.
Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
BJU Int; 2012 Dec; 110(11 Pt C):E1060-7. PubMed ID: 22686216
[TBL] [Abstract][Full Text] [Related]
5. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
6. [Current state of metaphylaxis of urinary stones in Russian Federation].
Malkhasyan VA; Gazimiev MA; Martov AG; Gadzhiev NK; Sukhikh SO; Pushkar DY
Urologiia; 2022 Nov; (5):46-52. PubMed ID: 36382817
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Urinary Stone Formers: Imaging Assessment and Endoscopic Treatment Strategies: A Systematic Search and Review.
Mavridis C; Bouchalakis A; Tsagkaraki V; Somani BK; Mamoulakis C; Tokas T
J Clin Med; 2024 Jun; 13(12):. PubMed ID: 38929988
[No Abstract] [Full Text] [Related]
8. [Socioeconomic aspects of urinary calculi and metaphylaxis of urinary calculi].
Strohmaier WL
Urologe A; 2000 Mar; 39(2):166-70. PubMed ID: 10768228
[TBL] [Abstract][Full Text] [Related]
9. Economic Considerations in the Management of Nephrolithiasis.
Roberson D; Sperling C; Shah A; Ziemba J
Curr Urol Rep; 2020 Mar; 21(5):18. PubMed ID: 32236700
[TBL] [Abstract][Full Text] [Related]
10. An Increase Incidence in Uric Acid Nephrolithiasis: Changing Patterns.
Kumari A; Dokwal S; Mittal P; Kumar R; Goel R; Bansal P; Kumar HD; Bhutani J
J Clin Diagn Res; 2016 Jul; 10(7):BC01-3. PubMed ID: 27630833
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in understanding and managing urolithiasis.
Strohmaier WL
F1000Res; 2016; 5():2651. PubMed ID: 27853528
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological trends in urolithiasis: impact on our health care systems.
Trinchieri A
Urol Res; 2006 Apr; 34(2):151-6. PubMed ID: 16440192
[TBL] [Abstract][Full Text] [Related]
13. Treatment alternatives for urinary system stone disease in preschool aged children: results of 616 cases.
Sen H; Seckiner I; Bayrak O; Erturhan S; Demirbağ A
J Pediatr Urol; 2015 Feb; 11(1):34.e1-5. PubMed ID: 25697981
[TBL] [Abstract][Full Text] [Related]
14. Improving the compliance of the recurrent stone-former.
Fritsche HM; Dötzer K
Arab J Urol; 2012 Sep; 10(3):342-6. PubMed ID: 26558047
[TBL] [Abstract][Full Text] [Related]
15. 5-year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy.
Osman MM; Alfano Y; Kamp S; Haecker A; Alken P; Michel MS; Knoll T
Eur Urol; 2005 Jun; 47(6):860-4. PubMed ID: 15925084
[TBL] [Abstract][Full Text] [Related]
16. [Current aspects of stone therapy].
Knoll T; Wendt-Nordahl G; Trojan L; Wenke A; Roeder N; Alken P
Aktuelle Urol; 2005 Feb; 36(1):47-54. PubMed ID: 15732004
[TBL] [Abstract][Full Text] [Related]
17. [Dual-energy computed tomography in the diagnostics of urolithiasis].
Kapanadze LB; Rudenko VI; Serova NS; Rapoport LM; Aleksandrova KA; Novikov AA
Urologiia; 2019 Dec; (5):31-36. PubMed ID: 31808629
[TBL] [Abstract][Full Text] [Related]
18. Metaphylaxis of nephrolithiasis.
Jacobellis U
Urol Int; 2007; 79 Suppl 1():51-5. PubMed ID: 17726353
[TBL] [Abstract][Full Text] [Related]
19. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
[TBL] [Abstract][Full Text] [Related]
20. Effect of medical management on recurrent stone formation following percutaneous nephrolithotomy.
Kang DE; Maloney MM; Haleblian GE; Springhart WP; Honeycutt EF; Eisenstein EL; Marguet CG; Preminger GM
J Urol; 2007 May; 177(5):1785-8; discussion 1788-9. PubMed ID: 17437820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
